Our annual ranking of America's largest corporations

471 of 500
BACKNEXT
471. Biogen Idec
Financials: Latest Results
Rank: 471 (Previous rank: 546)
CEO: James C. Mullen
Compare tool: Biogen Idec vs. Top 10
Subscribe to Fortune Magazine
Is Biogen Idec a great company, or what?
Key financials $ millions % change
from 2008
Revenues 4,377.3 6.8
Profits 970.1 23.9
Assets 8,551.9
Stockholders' equity 6,221.5
Market value (3/26/2010) 15,677.3
Profits as % of  
Revenues 22.2
Assets 11.3
Stockholders' equity 15.6
Earnings per share  
2009 $ 3.35
% change from 2008 26.4
1999-2009 annual growth rate % 27.9
Total return to investors %
2009 12.3
1999-2009 annual rate 5.0
Industry: Pharmaceuticals
Rank Company 500
rank
Revenues
($ millions)
1 Johnson & Johnson 33 61,897.0
2 Pfizer 40 50,009.0
3 Abbott Laboratories 75 30,764.7
4 Merck 85 27,428.3
5 Eli Lilly 112 21,836.0
6 Bristol-Myers Squibb 114 21,634.0
7 Amgen 159 14,642.0
8 Gilead Sciences 324 7,011.4
9 Mylan 412 5,092.8
10 Genzyme 458 4,515.5
11 Allergan 459 4,503.6
12 Biogen Idec 471 4,377.3
Issue date: May 3, 2010.
Interactives
  • A changing landscape
    See how revenues and profits at America's 25 largest companies have risen and fallen over the past decade.
  • Watch Wal-Mart grow
    From a single store in 1962 to more than 4,300 outlets today, see how the biggest retailer has expanded.
Headquarters
MAPS
Biogen Idec
14 Cambridge Center
Cambridge, MA 02142
617-679-2000
www.biogenidec.com
Find your top companies
 High revenue growth  High profit growth
 High EPS growth  High return to investors
 Top 5 in its industry  Best company to work for
 Big employer  Small employer



Video

Rank # of Fortune 500 Companies
California 57
Texas 57
New York 56
Company 2009 $ (millions)
Exxon Mobil $19,280.0
Microsoft $14,569.0
Wal-Mart Stores $14,335.0
FAQ and methodology
Included in the survey are U.S. incorporated companies filing financial statements with a government agency. This includes private companies... More
Current Issue
  • Give the gift of Fortune
  • Get the Fortune app
  • Subscribe